SCHEMBL25916808

SCHEMBL25916808

CCc1ccc(C(=O)N(C)c2ccc(OC)cc2-c2nc3ccccc3s2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.50
RXFP1 Q9HBX9 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
GAA P10253 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
KMT2A Q03164 1/20 0.50
TP53 P04637 5/20 0.48
RAB9A P51151 4/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
LMNA P02545 2/20 0.46
KDM4E B2RXH2 2/20 0.46
NPC1 O15118 1/20 0.46
PKM P14618 1/20 0.46
MGLL Q99685 1/20 0.45
MGAM O43451 2/20 0.45
ALDH1A1 P00352 1/20 0.44
PPARG P37231 1/20 0.44
NR2E3 Q9Y5X4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25916693 0.90 MAPT (0.55) MAPTRXFP1GAAKMT2ATP53
SCHEMBL25916722 0.80 NPC1 (0.54) MAPTRXFP1KMT2ATP53RAB9A
SCHEMBL25916711 0.76 LMNA (0.50) MAPTRXFP1GAAKMT2ATP53
SCHEMBL5429408 0.71 MAPT (0.64) MAPTRXFP1GAAKMT2ATP53
SCHEMBL30386590 0.71 MAPT (0.64) MAPTRXFP1GAAKMT2ATP53
SCHEMBL11755034 0.70 KDM4E (0.72) MAPTCYP1A2CYP3A4GAACYP2C9
SCHEMBL5981201 0.70 MAPT (0.71) MAPTRXFP1GAAKMT2ATP53
SCHEMBL30362766 0.69 MAPT (0.77) MAPTRXFP1KMT2ATP53RAB9A
SCHEMBL25916313 0.69 MAPT (0.77) MAPTRXFP1KMT2ATP53RAB9A
SCHEMBL25916518 0.69 MAPT (0.70) MAPTRXFP1CYP1A2CYP3A4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230235190-A1 FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS Crime Science Technology (FR) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230235190-A1 FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS TUBB3, TUBA3C, PHB1 MAPT 318/4885RXFP1 1340/4885CYP1A2 481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.